M

MHRA at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

MHRA takes part in 2 sessions at FoG London 2027 in London, its home city. Its sessions centre on the regulation of advanced therapy medicinal products (ATMPs), such as cell and gene therapies. They cover MHRA guidelines and clinical trial rules for these products and ways to lower risk and shorten the path to patients.

OrganizationFoG London 2027 Attendance
M
MHRA
London, UK
Government & non-profit
UK regulator of medicines and medical devices, including clinical trial and marketing approvals for advanced therapies.
Talk
Thu Jan 28
14:10–14:40
De-risking ATMP Innovation & Streamlining Pathways to Deliver Better Outcomes for Patients
How advanced cell and gene therapies could reach patients sooner through smarter trials, a new law allowing on-site manufacturing, and fairer research.
Talk
Thu Jan 28
16:40–17:10
Navigating MHRA Guidelines and Clinical Trial Regulations for ATMPs
How to apply to the UK medicines regulator for a clinical trial of an advanced cell or gene therapy, with practical tips.

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at MHRA

Tell us what you sell and we’ll find the people at MHRA most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction